Cite
Banaszkiewicz M, Constantinou M, Pietrusiński M, et al. Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy. Cent European J Urol. 2013;66(1):23-9doi: 10.5173/ceju.2013.01.art7.
Banaszkiewicz, M., Constantinou, M., Pietrusiński, M., Kępczyński, L., Jędrzejczyk, A., Rożniecki, M., Marks, P., & Kałużewski, B. (2013). Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy. Central European journal of urology, 66(1), 23-9. https://doi.org/10.5173/ceju.2013.01.art7
Banaszkiewicz, Monika, et al. "Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy." Central European journal of urology vol. 66,1 (2013): 23-9. doi: https://doi.org/10.5173/ceju.2013.01.art7
Banaszkiewicz M, Constantinou M, Pietrusiński M, Kępczyński L, Jędrzejczyk A, Rożniecki M, Marks P, Kałużewski B. Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy. Cent European J Urol. 2013;66(1):23-9. doi: 10.5173/ceju.2013.01.art7. Epub 2013 Apr 26. PMID: 24578981; PMCID: PMC3921859.
Copy
Download .nbib